Predictive Value of Albumin and Neutrophil-to-Lymphocyte Ratio Score for Treatment Completeness and Safety Profiles in Patients With Head and Neck Cancer Receiving Definitive Concurrent Chemoradiotherapy.

Chih-Chung Hsu,Wen-Chi Chou,Yu-Shin Hung,Shinn-Yn Lin,Chia-Yen Hung,Kun-Yun Yeh,Hung-Ming Wang,Chang-Hsien Lu

In vivo (Athens, Greece)（2022）

引用 0|浏览1

暂无评分

摘要

Our study showed that the ANS can accurately predict the treatment completeness of CCRT in patients with HNC and can be widely used as a simple predictor of treatment tolerance and safety profiles in patients with HNC undergoing CCRT.

查看译文

关键词

Taiwan,inflammation,prospective study,serious adverse events

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要